The company showed how they first defined A2A as the receptor required for mediating the effect of
adenosine on immune cells within the tumor microenvironment and reported the characterization of a novel immuno - oncology - dedicated adenosine receptor 2A antagonist that functions in the high adenosine concentration found in tumors.
Not exact matches
«
Adenosine deaminase may help the
immune system fight HIV
on its own:
Adenosine deaminase enhances anti-HIV-1 specific
immune responses by reducing the action of
cells that impede HIV - specific defenses.»
The
adenosine A2A receptor is the main
adenosine receptor expressed
on immune cells, which promotes
immune suppression, leading to tumor evasion.
The
adenosine A2A receptor is the main
adenosine receptor expressed
on immune cells, which promote anti-tumor
immune responses, leading to tumor regression when inhibited with an
adenosine A2A antagonist.
Binding of
adenosine to the A2A receptor
on immune cells blocks the activation and effector functions of anti-tumor
immune cells and promotes a regulatory,
immune - suppressive phenotype.
receptor is the main
adenosine receptor expressed
on immune cells, which promotes
immune suppression, leading to tumor evasion.
The
adenosine A ₂ ₐ receptor is the main
adenosine receptor expressed
on immune cell subsets including T -
cells, NK
cells and dendritic
cells and binding of
adenosine to the A ₂ ₐ receptor
on immune cells blocks the activation and effector functions of anti-tumor
immune cells and promotes a regulatory,
immune - suppressive phenotype.